Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
11/2008
11/12/2008CN101302233A Preparation of pentaerythritol diphosphonate melamine salt
11/12/2008CN101302232A Perfluoro alkyl phosphoester acrylic ester and preparation thereof
11/12/2008CN101302192A Prodrug forms of ribonucleotide reductase inhibitors 3-AP and 3-AMP
11/12/2008CN100432084C Non-metallocenes, method for production thereof and use thereof in polymerization of olefins
11/12/2008CN100432083C Phosphorus-oxazoline ligand with spiro backbone and its uses in asymmetrical catalytic hydrogenation
11/12/2008CN100432082C Synthesis method of chloro diisopropyl phosphine
11/12/2008CN100432081C Novel hydroxyaryl phosphine oxides,diglycidyl ethers and epoxy compositions, composites and laminates derived therefrom
11/11/2008US7449607 reacting formaldehyde with hydrogen and carbon monoxide in the presence of a catalyst comprising: a source of rhodium, and a ligand including a phospha-1,3,5,7-tetralkyl-6,9,10-trioxa-tricyclo[3.3.1.1{3,7}]-decyl group
11/11/2008US7449577 dehydration condensation of piperazine diphosphate; component of a flame retardant composition added to synthetic resins
11/11/2008US7449526 Thermoset resin composition of a hydroxy-terminated oligomeric phosphonate of diphenyl methyl-phosphonate and resorcinol and another flame retardant; circuit boards
11/06/2008WO2008134733A1 Oligomeric phosphonate compositions, their preparation and uses
11/06/2008WO2008134578A2 Synthesis of optically active radio-labeled reverse transcriptase inhibitors
11/06/2008WO2008134289A2 High relaxivity coordinatively unsaturated lanthanide complexes
11/06/2008WO2008133269A1 Ionic liquid, and polymer treatment agent comprising the ionic liquid
11/06/2008WO2008131635A1 Acyclic nucleoside phosphonate derivatives and their medical use
11/06/2008WO2008109740A3 Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers
11/06/2008WO2007140433A3 Methods and reagents for detecting bioactive lipids
11/06/2008WO2007109585A3 Bisphosphonate compounds and methods
11/06/2008WO2007098474A8 Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as s1p receptor agonists
11/06/2008US20080275273 Reaction of an olefin with a thiocarboxylic acid and subsequent hydrogenation to give the thiol, or with a dialkyl phosphonate and subsequent hydrolysis to give the phosphonic acid; self-assembling monolayers (SAM) for organic field-effect transistors (OFET); polymer electronics; cost efficiency
11/06/2008US20080275265 Dihydrobromide salt formation of 2-(3-aminopropylamino)ethanol and bromination with phosphorus tri- or pentabromide in sulfolane; thiophosphating the 2-(3-aminopropylamino)ethyl bromide dihydrobromide salt; purifying by recrystallization; cost efficiency; high yield and purity; radioprotectants
11/06/2008US20080275178 For printing inks; titanium halide/alkoxide and mixture comprising solution of apolymer or acetophenone-formaldehyde copolymer mixed with organophosphate; food packaging
11/06/2008US20080275008 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus
11/06/2008US20080275003 Phospholipase inhibitor; prevention or therapy of microbial infection; bactericides; fungicides; viricides; parasiticides; using quaternary or phosphonium group containing compounds
11/06/2008US20080274334 Dry Etching Gas and Method of Dry Etching
11/06/2008DE19753025B4 Optischer Datenspeicher und Verfahren zu dessen Herstellung Optical data storage device and process for its preparation
11/06/2008CA2685536A1 Oligomeric phosphonate compositions, their preparation and uses
11/06/2008CA2667150A1 Novel lipid compounds
11/05/2008EP1988084A1 Metal complex and use thereof
11/05/2008EP1988080A1 Insecticidal substituted 2-aminoindanes
11/05/2008EP1987046A1 An improved process for the preparation of biphosphonic derivatives
11/05/2008EP1987045A1 Process for the production of phosphorous compounds
11/05/2008EP1987044A1 Oligomeric and polymeric siloxanes substituted by arylphosphonic acids
11/05/2008EP1987013A1 Bicyclic sphingosine 1-phosphate analogs
11/05/2008EP1986607A2 Method and process for preparing cardiolipin
11/05/2008EP1836210B1 Process for the preparation of [1-hydroxy-2-(3-pyridinyl)ethyliden]bisphosphonic acid and hemi-pentahydrate monosodium salt thereof
11/05/2008EP1218383B1 Bicyclic imidazo-5-yl-amine derivatives
11/05/2008EP1216247B1 Imidazoimidazoles and triazoles as anti-inflammatory agents
11/05/2008CN101300263A Halophospholanes and their preparation
11/05/2008CN101300262A Bidentate C, P chiral phosphine ligands
11/05/2008CN101300014A Method of acting upon organism by targeted delivery of biologicaly active substances into m itochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose
11/05/2008CN101298460A Bidentate phosphite ester ligand, synthetic method and use thereof in alkene unsymmetrical catalysis hydroformylation reaction
11/05/2008CN101298056A Asymmetric catalytic reaction catalyst and preparation and use thereof
11/05/2008CN100430411C Activators for oligonucleotide synthesis
11/05/2008CN100430407C Di-2,4-dicumylphenyl pntaerythritol dphosphite preparation method
11/05/2008CN100430396C 2-phenyl-substituted imidazo-triazone used as phosphodiesterase inhibitor
11/05/2008CN100430390C Water-soluble triazole fungicide
11/05/2008CN100430344C Bidentate ligands of diolefin telomerization
11/05/2008CN100430139C Application of substituted bidentate amido phosphite ligand on binaphthol skeleton in hydroformylation of olefin
11/04/2008US7446228 Thiophosphine compounds
11/04/2008US7446140 Dialkylphosphinic salts, their use, and a process for their preparation
11/04/2008CA2443449C Pyrazole derivatives for treating hiv
11/04/2008CA2256328C Novel n-acylsulphonamides, novel mixtures of herbicides and antidotes and their use
10/2008
10/30/2008WO2008131270A1 Method for generating alkali metal phosphides through reduction of tri-substituted phosphines with alkali metal porous oxide compositions
10/30/2008WO2008131160A1 Ibandronate sodium polymorphs
10/30/2008WO2008131074A1 Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4-associated disorders
10/30/2008WO2008130678A2 Rosuvastatin intermediates and process for the preparation of rosuvastatin
10/30/2008WO2008130638A2 A process for preparing intermediates of hmg-coa reductase inhibitors
10/30/2008WO2008130368A2 Transcription factor modulating compounds and methods of use thereof
10/30/2008WO2008129785A1 Asymmetric catalyst having artificial double-strand
10/30/2008WO2008129407A2 Method for the preparation of phosphine butadiene ligands, complexes thereof with copper and use thereof in catalysis
10/30/2008WO2008128519A2 Aryl-substituted and/or heteroaryl-substituted main group element halides and/or pseudohalides, use of main group element halides and/or pseudohalides, organic semiconducting matrix material, electronic and optoelectronic components
10/30/2008WO2008098056A3 High relaxivity chelates
10/30/2008WO2008064320A3 Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity
10/30/2008WO2008056264A3 Novel nucleotide analogues as percursor molecules for antivirals
10/30/2008WO2008005542A3 Antiviral phosphinate compounds
10/30/2008WO2007109881A9 Biomarkers useful for diagnosing prostate cancer, and methods thereof
10/30/2008US20080269526 Methods of making an antistatic agent
10/30/2008US20080269524 Stereoisomers of 1-dimethylamino-3-(3-methoxyphenyl)-2-methylpentan-3-ol; possess analgesic activity without causing the side effects typical of opioids
10/30/2008US20080269501 Synthesis of Phosphono-Substituted Porphyrin Compounds for Attachment to Metal Oxide Surfaces
10/30/2008US20080269492 Ionic Compound
10/30/2008US20080269470 Dianionic chelating ligands with a bridged-bis-bi-aryl structure; For catalytic polymerization of ethylene/olefin copolymers
10/30/2008US20080269220 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
10/30/2008US20080269088 non-acidic, sulfur-containing, phosphorus-containing compound of the formula Such a compound may exhibit improved antiwear performance and thermal stability in lubricating compositions.
10/30/2008US20080268537 Free of nitrone; for reducing oxidative damage or delaying senescence
10/30/2008US20080267945 Salts of Isophosphoramide Mustard and Analogs Thereof as Anti-Tumor Agents
10/30/2008US20080267869 Technetium- or rhenium-imido group, strongly stabilized by presence of two ancillary tridentate and bidentate hetero-diphosphine ligands; radiodiagnostic imaging and radiotherapy
10/30/2008DE102008019744A1 1,3,2-Dioxaphosphorinan, 2-Sulfid-Derivate zur Verwendung als Anti-Verschleiß-Additive in Gleitmittel-Zusammensetzungen 1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions
10/30/2008CA2656157A1 Transcription factor modulating compounds and methods of use thereof
10/29/2008EP1633762B1 Paracyclophanes
10/29/2008EP1492776B1 Iodinated triglyceride analogs
10/29/2008CN101296933A Carbapenem compound
10/29/2008CN101293899A Acyclic nucleoside phosphonate derivative and medicine use thereof
10/29/2008CN101293898A Oxazoline derivative and preparation method thereof
10/29/2008CN101293897A Method for preparing O,O-ethyl thioether substituted phosphorus oxychloride
10/29/2008CN101293896A Preparation of low polyphosphate
10/29/2008CN101293895A Fine purification technique for phospholipid
10/29/2008CN101293894A 2-propylidene-19-nor-vitamin D compounds
10/29/2008CN100429216C Process for recovering a crystalline product from solution
10/28/2008US7442842 Method for asymmetric synthesis
10/28/2008US7442833 e.g. (2E)-3-(4-{(1Z)-2-phenyl-1-[4-(propionyloxy)phenyl]but-1-enyl}phenyl)prop-2-enoic acid; postmenopausal disorders, depressive symptoms; acylating anisole with 2-phenylbutanoic acid followed by demethylation, dehydration to yield phenol aldehyde, acylation and carboxylation to yield ester prodrug
10/28/2008US7442831 unsaturated phosphonic acids or anhydrides; monomers for the synthesis of polyphosphonic acids, used as corrosion inhibitors for water apparatus and antideposit agents in jet engines
10/28/2008US7442825 Making nitrile compounds from ethylenically unsaturated compounds
10/28/2008US7442737 Low acidity phosphate esters
10/28/2008US7442732 Hindered amine light stabilizers comprising neoalkanediol phosphites
10/28/2008US7442729 Composition of epoxy resin, polyphenolic compound and trisubstituted phosphonionphenolate salt
10/28/2008US7442718 Inhibitors of aspartyl protease
10/28/2008US7442689 Cardioprotective phosphonates and malonates
10/28/2008CA2487036C Process of making phosphordiamidite compounds
10/28/2008CA2298498C Process for the production of dithiophosphoric acid polysulfide mixtures
1 ... 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 ... 554